Jinhua Qinggan Granules eShow Global
Jinhua Qinggan Granules

聚协昌(北京)药业有限公司

Juxiechang (Beijing) Pharmaceutical Co., Ltd.

China    City:Beijing

Contact information
Visible after login
Product Promotion Page
Comment
Product Details

 

聚协昌产品介绍.jpg


1583984965678570.jpg

1583984965364299.jpg


金花清感颗粒可以用来提升免疫力、缓解感冒和流感带来的各种症状,包括:发烧、乏力、全身肌肉酸痛、鼻塞、感冒引起的咳嗽、咽痛、头痛。

Jinhua Qinggan Granules can strengthen immune system, relieve common cold/flu symptoms: fever, fatigue, muscle aches & painsnasal congestion, cough due to minor throat & bronchial irritation, sore throat, headache.

20201月,对102例轻型和普通型新冠肺炎患者金花清感颗粒临床对照研究,结果显示:金花清感颗粒组较西医组治疗,转重症率明显下降 (11.8% VS 29.4%);退热时间缩短(1.5天 VS 3);淋巴细胞复常率提高 (74.5% VS 64.7%)。结果表明金花清感颗粒治疗轻症和普通型具有确切的疗效。【1】

In January 2020, clinical controlled study of 102 patients with mild and common Coronavirus disease (COVID-19) showed that the Jinhua Qinggan Granules group compared with other medicine group had a significantly lower rate of becoming severe (11.8% VS 29.4%) ; the antipyretic time was shortened (1.5 days VS 3 days); lymphocyte recovery rate increased (74.5% vs 64.7%). The results show that Jinhua Qinggan Granules have proven effects on mild and common COVID-19 patients.【1】

2010年进行的前瞻性、非设盲、随机、对照测试中证明:金花清感颗粒在用于甲型H1N1流感病人时有退烧快(持续发烧时间金花清感颗粒组16小时、奥司他韦组20小时、空白组26小时、奥司他韦联合金花清感颗粒组15小时)、降低抗生素使用(抗生素使用率空白组34.3%、奥司他韦组15.7%、金花清感颗粒组9.7%、奥司他韦联合金花清感颗粒组7.8%)、安全可靠、有效减轻症状等特点。【2】

In a comparative randomized controlled non-blind test conducted in 2010, Jinhua Qinggan Granules proved that when used on H1N1 influenza patients, it can rapidly reduce and shorten fever(Continuous fever time: 16 hrs in Jinhua Qinggan Granules  group, 20 hrs in oseltamivir group, 26 hrs in controlled group, 15 hrs in Jinhua Qinggan Granules and oseltamivir combined group), reduce antibiotic use (antibiotic use was 34.3% in the controlled group, 15.7% in oseltamivir group, 9.7% in Jinhua Qinggan Granules group, 7.8% in Jinhua Qinggan Granules and oseltamivir combined group),  and effectively relieve of symptoms. 【2】

 

引用:Reference

【1】张伯礼院士:治疗新冠肺炎中西医各有所长. (2020, March 6). Retrieved March 8, 2020, from http://www.satcm.gov.cn/xinxifabu/meitibaodao/2020-03-06/13663.html

【2】Wang, C. & Cao, Bin & Liu, Q. & Zou, Z. & Liang, ZA & Gu, L. & Dong, J.. (2012). Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza. A randomized trial. (vol 155, pg 217, 2011). Annals of internal medicine. 156. 71-71. 10.1059/0003-4819-156-1-201201030-00031.

 



 

Comment
Comment